The FDA has approved BrainSense, an adaptive deep brain stimulation system that can adjust therapy for Parkinson’s disease in real time based on the patient’s brain activity, according to the ...
The biggest technical challenge for adaptive deep brain stimulation (aDBS) is how small brain signals are, Medtronic's Scott ...
The "U.S. Deep Brain Stimulation In Parkinson's Disease Market Size, Share & Trends Analysis Report By Product ...
The brain-computer interface technology uses an algorithm to adapt to an individual patient's needs, improving on previous tech that provided constant electrical brain stimulation. Other news includes ...
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of ...
The 10-million mark was reached in 2020. In 2024 around 2.7 million procedures were done and the cumulative total is over 17 ...
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results